Last updated on February 2018

Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)

Brief description of study

The purpose of this study is to compare the effects and safety of Anlotinib with placebo in patients with Gastric Cancer.

Clinical Study Identifier: NCT02461407

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.